PF-5274857
PF-5274857 is a potent, selective, orally active and brain-penetrant antagonist of Smo, with an IC50 of 5.8 nM and Ki of 4.6 nM. PF-5274857 has potential for research of tumor types including brain tumors and brain metastasis driven by an activated Hh pathway[1].
Product Specifications
CAS Number
1373615-35-0
UNSPSC
12352005
Hazard Statement
H317, H319
Target
Smo
Type
Reference compound
Related Pathways
Stem Cell/Wnt
Applications
Neuroscience-Neuromodulation
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pf-5274857.html
Purity
99.31
Solubility
DMSO : 125 mg/mL (ultrasonic) |H2O : < 0.1 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(N1CCN(C2=NC=C(Cl)C(C3=NC=C(C)C=C3C)=C2)CC1)CCS(=O)(C)=O
Molecular Formula
C20H25ClN4O3S
Molecular Weight
436.96
Precautions
H317, H319
References & Citations
[1]Rohner A, et al. Effective targeting of Hedgehog signaling in a medulloblastoma model with PF-5274857, a potent and selective Smoothened antagonist that penetrates the blood-brain barrier. Mol Cancer Ther. 2012, 11 (1), 57-65.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402281-100 1x 100 µL
HLA-DRB (MHC II) (DA2), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
LC403103 20 µg
HNRPM (HNRNPM) (NM_031203) Human Over-expression Lysate
Sign In for Pricing
View Details